Fusion of SPECT with computed tomography or magnetic resonance for the interpretation of abnormal tracer uptake;Utilidad clínica de la fusión SPECT/CT con marcadores externos en patología oncológica

Revista Medica de Chile

Volumn 135, Issue 6, 2007, Pages 725-734

  Aqueveque A, Carolina ^a   González Espinoza, Patricio ^a,b   Gutiérrez B, Daniela ^a   Jaimovich F, Rodrigo ^a   Díaz P, Juan Carlos ^b   Csendes G, Paula ^b   Orellana P, Patricia ^b   Lavados M, Hugo ^a   Alliende G, Isabel ^a   Araya L, Sandra ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Magnetic resonance imaging; Thyroid neoplasms; Tomography emission computed, Single photon

Indexed keywords

EID: 34548348317     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. SLOMKA PJ. Software approach to merging molecular with anatomic information. J Nucl Med 2004; 45 Suppl 1: 36S-45S.
2. HUTTON B, BRAUN M. Software for image registration: Algorithms, accuracy, efficacy. Sem Nucl Med 2003; 33: 180-92.
3. BOCHER M, BALAN A, KRAUSZ Y, SHREM Y, LONN A, WILK M ET AL. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur J Nucl Med 2000; 27: 619-27.
4. PATTON JA, DELBEKE D, SANDLER MP. Image fusion using an integrated, dual-head coincidence camera with x-ray tube-based attenuation maps. J Nucl Med 2000; 41: 1364-8.
5. ISRAEL O, KEIDAR Z, IOSILEVSKY G, BETTMAN L, SACHS J, FRENKEL A. The fusion of anatomic and physiologic imaging in the management of patients with cancer. Semin Nucl Med 2001; 31: 191-205.
6. KEIDAR Z, ISRAEL O, KRAUSZ Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Sem Nucl Med 2003; 33: 205-18.
7. MALIK EJ, BRUCE DC. Positron-Emission Tomography and Assessment of Cancer Therapy. N Engl J Med 2006; 354: 496-507.
8. SHREVE P. Adding structure to function. J Nucl Med 2000; 41: 1380-2.
9. TOWNSEND DW, CHERRY SR. Combining anatomy and function: the path to true image fusion. Eur Radiol 2001; 11: 1968-74 (abstract).
10. MAES F, COLLIGNON A, VANDERMEULEN D, MARCHAL G, SUETENS P. Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 1997; 16: 187-98 (abstract).
11. AQUEVEQUE C, GONZÁLEZ P, HERRMANN R, CERECEDA M. Primera fusión SPECT Sestamibi y Cardiorresonancia para estudio de viabilidad: caso clínico. Alasbimn Journal 2005; 7: 27. Disponible en: http://www2.alasbimnjournal.cl [Consultado 20 Marzo 2005]
12. PELOSI E, MESSA C, SIRONI S, PICCHIO M, LANDONI C, BETTINARDI V ET AL. Value of integrated PET/CT for lesion localization in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging 2004; 31: 932-9.
13. GUTMAN F, HANGARD G, GARDIN I, VARMENOT N, PATTYN J, CLEMENT JF ET AL. Evaluation of a Rigid Registration Method of Lung Perfusion SPECT and Thoracic CT. AJR Am J Roentgenol 2005; 185: 1516-24.
14. AQUEVEQUE C, GONZÁLEZ P, DÍAZ JC, CSENDES P, JAIMOVICH R, GUTIÉRREZ D. Utilidad clínica de la fusión SPECT/ CT en cáncer diferenciado de tiroides. Alasbimn Journal 2005; 7: 27. Disponible en: http://www2.alasbimnjournal.cl [Consultado 20 Marzo 2005].
15. YAMAMOTO Y, NISHIYAMA Y, MONDEN T, MATSUMURA Y, SATOH K, OHKAWA M. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med 2003; 44: 1905-10.
16. MAURER CR, MACIUNAS RJ, FITZPATRICK JM. Registration of head CT images to physical space using a weighted combination of points and surfaces. IEEE Trans Med Imaging 1998; 17: 753-61 (abstract).
17. THARP K, ISRAEL O, HAUSMANN J, BETTMAN L, MARTIN WH, DAITZCHMAN M ET AL. Impact of I131 SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging 2004; 31: 1435-42.
18. BEYER T, TOWNSEND DW, BRUN T, KINAHAN PE, CHARRON M, RODDY R ET AL. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-79.
19. MESSA C, BETTINARDI V, PICCHIO M, PELOSI E, LANDONI C, GIANOLLI L ET AL. PET/CT in diagnostic oncology. Q J Nucl Med Mol Imaging 2004; 48: 66-75.
20. SCHILLACI O, SIMONETTI G. Fusion imaging in nuclear medicine- applications of dual-modality system in oncology. Cancer Biother Radiopharm 2004; 19: 1-10.
21. ISRAEL O, YEFREMOV N, MOR M, HAIM N, GAITINI D, EPELBAUM R ET AL. A new technology of combined transmission (CT) and emission Ga-67 tomography (TET) in the evaluation of patients with lymphoma. J Nucl Med 2000; 41: 70P.
22. KANEMATSU M, KONDO H, GOSHIMA S, KATO H, TSUGE U, HIROSE Y ET AL. Imaging liver metastases: Review and update. Eur J Radiol 2006; 58: 217-28.
23. JAMES W. Reinig Differentiation of Hepatic Lesions with MR Imaging: The Last Word? Radiology 1991; 179: 601-2.
24. KRAUSZ Y, KEIDAR Z, KOGAN I, EVEN-SAPIR E, BAR-SHALOM R, ENGEL A ET AL. SPECT/CT hybrid imaging with 111In-pentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf) 2003; 59: 565-73.
25. AMTHAUER H, RUF J, BOHMIG M, LÓPEZ-HANNINEN E, ROHLFING T, WERNECKE KD ET AL. Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit? Eur J Nucl Med Mol Imaging 2004; 31: 342-8.
26. FORSTER GJ, LAUMANN C, NICKEL O, KANN P, RIEKER O, BARTENSTEIN P. SPET/CT image co-registration in the abdomen with a simple and cost-effective tool. Eur J Nucl Med Mol Imaging 2003; 30: 32-9.
27. MAZZAFERRI E, KLOOS R. Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer. JCE & M 2001; 86: 1447-63.
28. VARIOS AUTORES. Guías de procedimiento de la Sociedad Americana de Medicina Nuclear disponibles en http://interactive.snm. org/index.cfm?PageID=772 [Consultado 20 Marzo 2005].
29. MCDOUGALL IR. Whole-body scintigraphy with radioiodine-131. A comprehensive list of false-positives with some examples. Clin Nucl Med 1995; 20: 869-75.
30. OZGUVEN M, ILGAN S, ARSLAN N, KARACALIOGLU AO, YUKSEL D, DUNDAR S. Unusual patterns of I-131 contamination. Ann Nucl Med 2004; 18: 271-4.
31. BAKHEET SM, HAMMAMI MM. False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology. Clin Nucl Med 1994; 19: 325-9.
32. SALVATORI M, SALETNICH I, RUFINI V, TRONCONE L. Unusual false-positive radioiodine whole-body scans in patients with differentiated thyroid carcinoma. Clin Nucl Med 1997; 22: 380-4.
33. DAVIDSON J, MCDOUGALL IR. How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans? Eur J Nucl Med 2000; 27: 425-30.
34. WILSON LM, BARRINGTON SF, MORRISON ID, KETTE AG, O'DOHERTY MJ, COAKLEY AJ. Therapeutic implications of thymic uptake of radioiodine in thyroid carcinoma. Eur J Nucl Med 1998; 25: 622-8.
35. VERONIKIS IE, SIMKIN P, BRAVERMAN LE. Thymic uptake of iodine-131 in the anterior mediastinum. J Nucl Med 1996; 37: 991-2 (abstract).
36. MICHIGISHI T, MIZUKAMI Y, SHUKE N, YOKOYAMA K, NOGUCHI M, WATANABE Y ET AL. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer. Eur J Nucl Med 1993; 20: 75-9.
37. PICOLOS MK, HABRA M, SAFDAR A, SARLIS NJ. Inactive Pulmonary Tuberculosis Mimicking Metastasis from Papillary Thyroid Carcinoma in Diagnostic Radioiodine Whole-Body Scintigraphy. Thyroid 2005; 15: 1105-6.
38. SONG HC, HEO YJ, KIM SM, BOM HS. Iodine-131 uptake in focal bronchiectasis mimicking metastatic thyroid cancer. Clin Nucl Med 2003; 28: 351-2.
39. BAKHEET SM, HAMMAMI MM, POWE J, BAZARBASHI M, AL SUHAIBANI H. Radioiodine uptake in inactive pulmonary tuberculosis. Eur J Nucl Med 1999; 26: 659-62.